| Symbol | AMIX |
|---|---|
| Name | AUTONOMIX MEDICAL, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 21 WATERWAY AVENUE,SUITE 300, THE WOODLANDS, Texas, 77380, United States |
| Telephone | +1 713 - 588-6150 |
| Fax | — |
| — | |
| Website | https://www.autonomix.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001617867 |
| Description | Autonomix, were developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. Additional info from NASDAQ: |
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
Read moreAutonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
Read moreAutonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
Read moreAutonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
Read more(99% Neutral) AUTONOMIX MEDICAL, INC. (AMIX) Announces Business Combination
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreAutonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
Read moreAutonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
Read moreAutonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant
Read more